Scott Eblen to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Scott Eblen has written about Drug Resistance, Neoplasm.
Connection Strength
0.696
-
EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis. 2014 May; 35(5):1100-9.
Score: 0.372
-
Regulation of chemoresistance via alternative messenger RNA splicing. Biochem Pharmacol. 2012 Apr 15; 83(8):1063-72.
Score: 0.324